New agents and combinations in the treatment of bronchogenic carcinoma.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001761:Bleomycin / Q000494:pharmacology / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D002477:Cells / Q000187:drug effects; D002478:Cells, Cultured; D006224:Cricetinae; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008938:Mitosis / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D010053:Ovary; D014750:Vincristine / Q000494:pharmacology / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D001761:Bleomycin; D014750:Vincristine; D003520:Cyclophosphamide